Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 2
1985 2
1986 4
1987 1
1988 2
1989 4
1990 1
1991 2
1993 3
1994 3
1995 2
1996 2
1997 3
1998 2
1999 2
2000 5
2001 2
2002 3
2003 3
2004 3
2005 7
2006 10
2007 10
2008 9
2009 10
2010 4
2011 6
2012 4
2013 5
2014 12
2015 5
2016 7
2017 8
2018 3
2019 4
2020 7
2021 4
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Editorial overview: Antigen processing.
De Libero G. De Libero G. Curr Opin Immunol. 2018 Jun;52:iv-v. doi: 10.1016/j.coi.2018.05.016. Curr Opin Immunol. 2018. PMID: 29907238 No abstract available.
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
Chancellor A, Alan Simmons R, Khanolkar RC, Nosi V, Beshirova A, Berloffa G, Colombo R, Karuppiah V, Pentier JM, Tubb V, Ghadbane H, Suckling RJ, Page K, Crean RM, Vacchini A, De Gregorio C, Schaefer V, Constantin D, Gligoris T, Lloyd A, Hock M, Srikannathasan V, Robinson RA, Besra GS, van der Kamp MW, Mori L, Calogero R, Cole DK, De Libero G, Lepore M. Chancellor A, et al. Among authors: de libero g. J Exp Med. 2023 Sep 4;220(9):e20221939. doi: 10.1084/jem.20221939. Epub 2023 Jun 29. J Exp Med. 2023. PMID: 37382893 Free PMC article.
MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
Vacchini A, Chancellor A, Spagnuolo J, Mori L, De Libero G. Vacchini A, et al. Among authors: de libero g. Front Immunol. 2020 Apr 28;11:751. doi: 10.3389/fimmu.2020.00751. eCollection 2020. Front Immunol. 2020. PMID: 32411144 Free PMC article. Review.
Mitochondrial Proteins as Source of Cancer Neoantigens.
Prota G, Lechuga-Vieco AV, De Libero G. Prota G, et al. Among authors: de libero g. Int J Mol Sci. 2022 Feb 27;23(5):2627. doi: 10.3390/ijms23052627. Int J Mol Sci. 2022. PMID: 35269772 Free PMC article. Review.
From Immunologically Archaic to Neoteric Glycovaccines.
Cavallari M, De Libero G. Cavallari M, et al. Among authors: de libero g. Vaccines (Basel). 2017 Jan 27;5(1):4. doi: 10.3390/vaccines5010004. Vaccines (Basel). 2017. PMID: 28134792 Free PMC article. Review.
The Conventional Nature of Non-MHC-Restricted T Cells.
Lepore M, Mori L, De Libero G. Lepore M, et al. Among authors: de libero g. Front Immunol. 2018 Jun 14;9:1365. doi: 10.3389/fimmu.2018.01365. eCollection 2018. Front Immunol. 2018. PMID: 29963057 Free PMC article. Review.
Novel insights into lipid antigen presentation.
De Libero G, Mori L. De Libero G, et al. Trends Immunol. 2012 Mar;33(3):103-11. doi: 10.1016/j.it.2012.01.005. Epub 2012 Feb 16. Trends Immunol. 2012. PMID: 22342205 Review.
The Immunology of CD1- and MR1-Restricted T Cells.
Mori L, Lepore M, De Libero G. Mori L, et al. Among authors: de libero g. Annu Rev Immunol. 2016 May 20;34:479-510. doi: 10.1146/annurev-immunol-032414-112008. Epub 2016 Feb 25. Annu Rev Immunol. 2016. PMID: 26927205 Review.
'Bohemian Rhapsody' of MR1T cells.
Mori L, De Libero G. Mori L, et al. Among authors: de libero g. Nat Immunol. 2020 Feb;21(2):108-110. doi: 10.1038/s41590-019-0588-6. Nat Immunol. 2020. PMID: 31959981 No abstract available.
163 results